Waters Corporation announced on April 1, 2025, the expansion of its Alliance™ iS Bio HPLC product line with integrated photodiode array (PDA) detection. This advancement enhances the capabilities of the next-generation intelligent HPLC platform, specifically designed for biopharmaceutical development and Quality Control (QC) laboratories.
The addition of PDA detection allows biopharmaceutical laboratories to perform enhanced spectral analysis, including impurity detection, peak purity analysis, and multi-wavelength detection. When paired with MaxPeak Premier columns, the Alliance iS Bio HPLC System enhances out-of-the-box sensitivity by up to 80 times compared to traditional systems and columns.
The Alliance iS HPLC Platform is engineered to simplify laboratory workflows by reducing the risk of out-of-specification results and the need for troubleshooting. It provides over threefold improvement in day-to-day reproducibility and reduces carryover by up to two orders of magnitude compared to other market systems.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.